Gene Query: COPS7B

Dataset Description Geneva Score
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 37.64
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 35.63
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 22.61
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 21.1
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 18.45
SUV420H2 knockdown in PANC-1 14.94
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 14.8
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 13.74
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 12.82
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 11.9
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 11.28
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 10.75
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 10.68
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 10.22
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.9
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 9.86
Impact of dieldrin on transcription in Jurkat T cells 9.41
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 9.31
HNF1A deficiency impairs β-cell fate, granule maturation and function 8.9
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 8.19
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 7.5
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 7.34
The role of FAM46C in myeloma cells 7.17
The role of FAM46C in myeloma cells [sequencing] 7.17
scRNASeq analysis of cycling cardiomyocytes 7.0
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 7.0
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 6.88
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.81
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 6.72
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 6.64
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 6.63
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.62
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 6.51
Gene expression analysis of the impact of TDP-43 knockout in human cells. 6.49
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 6.43
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 6.43
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.29
Identification of Atrial Fibrillation associated genes and functional non-coding variants 6.11
Depicting early human development and germ cell origin with porcine embryos 6.1
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 6.09
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 6.03
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 5.99
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 5.96
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.94
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 5.92
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.84
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 5.79
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.77
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.77
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 5.74
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 5.65
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 5.63
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 5.55
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 5.55
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 5.51
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 5.51
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 5.44
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 5.39
Generation and persistence of human tissue-resident memory T cells in lung transplantation 5.34
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 5.21
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.16
Gene expression profiling of leukemia cells following asparagine depletion 5.09
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 5.08
Integrating single-cell transcriptomic data across different conditions, technologies, and species 5.06
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 5.04
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.02
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.94
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 4.94
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.88
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.84
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 4.81
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 4.8
Altering cancer transcriptomes using epigenomic inhibitors 4.75
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 4.75
High-throughput sequencing of pluripotent cells 4.72
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.71
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.71
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.68
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 4.64
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 4.64
Global Mapping of Human RNA-RNA Interactions 4.61
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.59
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 4.58
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 4.58
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.58
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.56
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 4.54
ENCODE Cold Spring Harbor Labs Long RNA-seq 4.5
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 4.38
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 4.38
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 4.35
LINE-2 transposable elements are a source of functional human microRNAs and target sites 4.33
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 4.33
Expression and functions of long noncoding RNAs during human T helper cell differentiation 4.3
DAOY-Notch1/Notch2 knockout: transcriptome comparison 4.3
Cleavage Factor Im as a key regulator of 3’ UTR length 4.28
Paxillin regulates genomic networks in prostate cancer [PC3] 4.26
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 4.26
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.25
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.25
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 4.19
An integrative analysis of non-coding regulatory DNA variations associated with autism 4.07
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 4.06
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 4.03
PTHrP overexpression in MCF7 cells 4.02
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.02
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 4.01
PRDM1 inhibits proliferation of human colon cancer organoids 3.99
CD73 knockdown effect in pancreatic cancer cell lines 3.98
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 3.95
Transcriptomic analyssis following EHMT1/2 inhibition 3.94
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 3.93
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 3.91
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 3.86
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 3.85
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 3.78
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 3.74
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 3.74
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 3.68
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 3.64
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 3.64
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.64
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 3.63
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.56
RNA sequencing analysis of human embryonic stem cells and axial progenitors 3.56
Identification of renal resident macrophages across species 3.55
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 3.53
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 3.51
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.48
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 3.4
Human Treg NaCl stimulation 3.34
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 3.33
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 3.3
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 3.29
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 3.29
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 3.28
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 3.28
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 3.28
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 3.24
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 3.24
Dynamic 3D chromosomal landscapes in acute leukemia 3.23
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 3.23
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 3.22
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 3.22
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 3.18
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.15
Differentially expressed vascular development genes for iPSC-ECs from CDI 3.14
ETV7 and interferon response 3.12
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 3.12
Gene expression in GBM with Cav3.2 inhibition 3.12
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 3.12
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 3.12
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 3.1
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 3.1
SLIGRL-induced gene expression changes in NHEK cells 3.09
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.06
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 3.06
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.05
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 3.03
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 3.02
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 3.02
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 3.02
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.02
High-efficiency RNA-based reprogramming of human primary fibroblasts 3.01
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 2.98
Generating Patterned Kidney Organoids for Studying Development and Diseases 2.98
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 2.96
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 2.93
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 2.93
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 2.93
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.92
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 2.89
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 2.89
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.89
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.89
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 2.89
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 2.89
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.88
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.88
Capturing the Interactome of Newly Transcribed RNA 2.88
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.87
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 2.85
RNA-seq analysis of differentiating human erythroblasts 2.83
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 2.82
HEXIM1 is induced by DHODH inhibition to suppress melanoma 2.82
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 2.82
U1 snRNP telescripting regulates size-function stratified human genome 2.8
Global analysis of enhancer targets: Mosaic-seq 2.8
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 2.79
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 2.78
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 2.78
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 2.77
Chromatin-informed inference of transcriptional programs in gynecologic cancers 2.77
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.76
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 2.76
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.74
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 2.74
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 2.73
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 2.73
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.72
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 2.72
Neonatal and adult human testis defined at the single-cell level 2.67
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 2.67
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 2.67
snRNAs as regulators of alternative splicing 2.64
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.62
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.58
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 2.57
Single-cell analysis of adult human ovary using 10X genomics 2.55
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 2.53
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 2.53
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.52
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.52
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 2.51
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 2.51
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 2.51
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 2.49
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.47
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 2.45
Lysine benzoylation is a novel histone mark 2.43
Lysine benzoylation is a novel histone mark [RNA-seq] 2.43
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.42
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.42
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.41
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.4
Effect of from Human Umbilical Vein Endothelial Cells 2.39
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 2.38
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 2.37
Landscape and variation of RNA secondary structure across the human transcriptome 2.36
O-glcnAc reprograms cellular energetics 2.36
Transciptomic profiling of human fetal lung samples 2.35
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.33
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 2.32
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 2.31
Biological effect of chronic mistranslation in mammalian cells 2.3
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 2.29
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.28
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 2.28
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 2.28
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 2.27
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 2.27
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 2.27
RNAseq Study in CC-671 Treated Cal-51 Cells 2.26
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.26
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.26
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.26
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 2.25
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 2.25
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 2.25
Nutritional control of protein translation 2.23
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 2.23
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 2.22
Global transcriptome analysis of HAP1 cells 2.22
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 2.21
Differential Protein Occupancy Profiling of the mRNA Transcriptome 2.2
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.19
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.18
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 2.16
Gene Expression Profiling of WT and KDM3A Knocked out Cell 2.16
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.14
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 2.13
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 2.13
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.11
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.08
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.08
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 2.07
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 2.07
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.07
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 1.99
Single-Cell Genotyping of Transcriptomes 1.99
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.99
METTL3 and WTAP 1.99
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.99
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 1.99
EWSR1 influences alternative splicing through direct and indirect mechanisms 1.97
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 1.97
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.96
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.96
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.95
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.94
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 1.94
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 1.94
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 1.92
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 1.92
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 1.85
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.83
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.82
Identification of a LIF-responsive replication-competent human β cell 1.82
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 1.8
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.79
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.78
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.77
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.77
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.76
TT-Seq captures the human transient transcriptome 1.75
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.74
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.74
Glioblastoma stem cells infected by ZIKA virus 1.72
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.7
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 1.69
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.68
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 1.67
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.64
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.64
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 1.64
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.62
N6-methyladenine DNA Modification in Glioblastoma 1.62
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 1.62
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.62
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 1.6
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.59
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.57
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.57
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.56
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 1.53
Co-regulation of splicing by Rbfox1 and hnRNP M 1.53
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 1.52
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.46
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.44
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.44
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.42
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.41
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 1.4
The bromodomain protein BRD4 regulates splicing during heat shock 1.4
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.39
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.38
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.37
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.33
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.33
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 1.32
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 1.32
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.31
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.31
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.3
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.28
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.28
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.27
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.26
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.26
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.26
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.24
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 1.19
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 1.19
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.18
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.18
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.16
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.15
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.14
RNA-seq analysis upon ARID1B overexpression 1.14
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.13
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.13
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 1.12
RNA editing in nascent RNA affects pre-mRNA splicing 1.11
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.1
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 1.1
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.09
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.09
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.09
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.08
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.07
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.03
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.03
The cohesin complex prevents Myc-induced replication stress 1.02
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.02
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 1.01
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 1.01
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.0
Functional significance of the HIV-1 Tat signature amino acid residues 0.99
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.98
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 0.98
Determining mRNA half-lives on a transcriptome-wide scale 0.97
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.97
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.96
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.96
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.95
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.94
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.93
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 0.93
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.88
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 0.87
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.86
Gene expression analysis upon mtDNA depletion 0.86
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.85
Transcriptome analysis of CNS leukemia 0.85
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.85
Human neutrophil genome during PMA- and E. coli encounter-induced activation 0.83
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 0.83
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.83
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.83
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.8
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.8
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.8
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.79
Transposon-based construction of strand-specific RNA-seq libraries 0.76
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.75
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.75
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.75
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.75
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.73
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.71
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 0.7
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.69
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.67
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.67
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.64
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.64
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.63
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.63
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.6
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.59
quanTIseq: quantifying immune contexture of human tumors 0.55
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.55
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 0.54
The MEF2B Regulatory Network 0.53
The MEF2B Regulatory Network - RNA-seq data 0.53
Measure transcript integrity using RNA-seq data 0.53
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.51
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.49
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 0.49
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 0.49
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.48
RNA splicing alteration on glioblastoma and normal neural stem cells 0.47
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.47
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.45
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.45
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.45
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.45
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.45
Myc activation coordinates gene transcription and protein translation responses 0.42
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.41
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.41
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.4
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.4
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.39
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.38
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 0.37
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.37
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.36
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.35
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.35
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.33
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.32
Epigenomic conservation of transposable element silencing [RNA-seq] 0.32
Epigenomic conservation of transposable element silencing 0.32
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.31
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.31
The circadian transcriptional landscape in primary human mammary epithelial cells 0.31
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.3
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.3
MicroRNA-125a-5p overexpression in human macrophages 0.3
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 0.3
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.28
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.27
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.27
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.25
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.25
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.25
RNA seq with AML (NB4) cells upon FTO inhibition 0.24
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.23
Role of FGFR1 in neuronal devlopment 0.23
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.22
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 0.22
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.21
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.2
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.19
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.18
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.18
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.17
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.17
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.16
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.16
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.15
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.15
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.15
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.13
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.12
SOX11 knockdown in B-ALL cell lines 0.12
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.12
RNA transcriptome analysis during HSV-1 infection 0.11
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.11
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.1
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 0.09
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.07
Illumina Total RNA-seq in HeLa 0.07
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.07
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.07
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.06
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.06
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.06
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.04
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.04
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.04
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.04
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.02
MHC Transcriptomic landscape at haplotype-specific resolution 0.02
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 0.01
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.01
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.01
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.0
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation